Thermal threshold for localized Blood-Brain-Barrier disruption
Authors:
Sébastien Bär,
Oliver Buchholz,
Christian Münkel,
Paul Schlett,
Pierre Levan,
Dominik von Elverfeldt,
Ulrich G. Hofmann
Abstract:
The Blood-Brain Barrier is the gatekeeper of the CNS. It effectively shields the brain from blood-borne harm but simultaneously represents a significant challenge for treating neurological diseases. Altering its permeability enables increasing the local drug concentration and thereby improving the therapeutic effect. Although permeability increase is achieved by raised tissue temperature, the dete…
▽ More
The Blood-Brain Barrier is the gatekeeper of the CNS. It effectively shields the brain from blood-borne harm but simultaneously represents a significant challenge for treating neurological diseases. Altering its permeability enables increasing the local drug concentration and thereby improving the therapeutic effect. Although permeability increase is achieved by raised tissue temperature, the determination of the thermal dosage suffers from imprecise thermometry during hyperthermia application. Knowledge of the thermal dosage is crucial for improving hyperthermia related interventions of the CNS. Here we show an approach to determine the thermal threshold for localized Blood-Brain Barrier disruption estimated by MR thermometry.
Methods: Using an IR laser (λ = 1470nm) we showed that highly localized Blood-Brain Barrier opening can be achieved with mild to moderate hyperthermia. Non-invasive MR thermometry has been used to determine the temperature at the heating site. Blood-Brain Barrier opening has been monitored by DCE-MRI in vivo and post mortem via Evan's Blue extravasation. Results: The Blood-Brain Barrier permeability can be altered locally with minimal thermal dosages. Thus mild hyperthermia represents a promising approach to making the brain accessible for therapeutic interventions.
△ Less
Submitted 15 June, 2023;
originally announced June 2023.
In situ theranostic platform uniting highly localized magnetic fluid hyperthermia, magnetic particle imaging, and thermometry in 3D
Authors:
Oliver Buchholz,
Kulthisa Sajjamark,
Jochen Franke,
Huimin Wei,
André Behrends,
Christian Münkel,
Cordula Grüttner,
Pierre Levan,
Dominik von Elverfeldt,
Matthias Gräser,
Thorsten Buzug,
Sébastien Bär,
Ulrich G. Hofmann
Abstract:
In all of medical profession a broad field of research is dedicated to seek less invasive and low-risk forms of therapy with the ultimate goal of non-invasive therapy, particularly in neoplasmic diseases. Theranostic platforms, combining diagnostic and therapeutic approaches within one system, have thus garnered interest to augment invasive surgical, chemical, and ionizing interventions. Magnetic…
▽ More
In all of medical profession a broad field of research is dedicated to seek less invasive and low-risk forms of therapy with the ultimate goal of non-invasive therapy, particularly in neoplasmic diseases. Theranostic platforms, combining diagnostic and therapeutic approaches within one system, have thus garnered interest to augment invasive surgical, chemical, and ionizing interventions. Magnetic particle imaging (MPI) offers, with its versatile tracer material (superparamagnetic iron oxide nanoparticles, SPIOs), a quite recent alternative to established radiation based diagnostic modalities. In addition, MPI lends a bimodal theranostic frame allowing to combine tomographic imaging with therapy techniques using the very same SPIOs. In this work, we show for the first time the interleaved combination of MPI-based imaging, therapy (highly localized magnetic fluid hyperthermia) and therapy safety control (MPI-based thermometry) within one theranostic platform in all three spatial dimensions.
△ Less
Submitted 17 April, 2023; v1 submitted 13 April, 2023;
originally announced April 2023.
